InsiderSignal.AI

InsiderSignal.ai

KYTX - Kyverna Therapeutics, Inc.

Insider Purchase by Seidenberg Beth C (Dir)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

2 months ago, Seidenberg Beth C, serving as Dir at Kyverna Therapeutics, Inc. (KYTX), purchased 133,333 shares at $7.50 per share, for a total transaction value of $999,998.00. Following this transaction, Seidenberg Beth C now holds 4,673,891 shares of KYTX.

This purchase represents a 3.00% increase in Seidenberg Beth C's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, December 18, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 22, 2025, 4 days after the trade was made.

Kyverna Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Seidenberg Beth C

Seidenberg Beth C

Dir

Beth C. Seidenberg, M.D. is a Director at Kyverna Therapeutics, Inc. (KYTX), a position she has held since September 2018.[[1]](https://fintool.com/app/research/companies/SGMT/people/beth-seidenberg)[[4]](https://kyvernatx.com/inside-kyverna/beth-seidenberg-md/) She is a founding Managing Director at Westlake Village BioPartners (since 2018) and previously served as a Managing Member of Kleiner Perkins life sciences funds, where she incubated and invested in over 40 biotech companies.[[1]](https://fintool.com/app/research/companies/SGMT/people/beth-seidenberg)[[2]](https://latigobio.com/staff-member/beth-seidenberg-m-d/)[[4]](https://kyvernatx.com/inside-kyverna/beth-seidenberg-md/)[[6]](https://westlakebio.com/team-members/beth-seidenberg-md/) Dr. Seidenberg has a distinguished career in biotechnology, with senior R&D executive roles at Amgen (SVP, Head of Global Development & Chief Medical Officer), Bristol Myers Squibb, and Merck, where she developed treatments for diseases including AIDS, arthritis, asthma, cancer, psoriasis, cardiovascular, metabolic, neurological, and renal disorders, introducing 10 innovative products to market over 20 years.[[1]](https://fintool.com/app/research/companies/SGMT/people/beth-seidenberg)[[2]](https://latigobio.com/staff-member/beth-seidenberg-m-d/)[[4]](https://kyvernatx.com/inside-kyverna/beth-seidenberg-md/)[[5]](https://hbanet.org/2022-woman-of-the-year-beth-seidenberg-md)[[6]](https://westlakebio.com/team-members/beth-seidenberg-md/) She also serves on the boards of Sagimet Biosciences (since 2007, Chair of Compensation Committee), Vera Therapeutics, Acelyrin, and others.[[1]](https://fintool.com/app/research/companies/SGMT/people/beth-seidenberg)[[2]](https://latigobio.com/staff-member/beth-seidenberg-m-d/) Dr. Seidenberg earned a B.S. in biology and anthropology from Barnard College and an M.D. from the University of Miami, with residency training at Johns Hopkins University and George Washington University, and a fellowship at the NIH.[[1]](https://fintool.com/app/research/companies/SGMT/people/beth-seidenberg)[[2]](https://latigobio.com/staff-member/beth-seidenberg-m-d/)[[4]](https://kyvernatx.com/inside-kyverna/beth-seidenberg-md/)[[5]](https://hbanet.org/2022-woman-of-the-year-beth-seidenberg-md)[[6]](https://westlakebio.com/team-members/beth-seidenberg-md/)

View full insider profile →

Trade Price

$7.50

Quantity

133,333

Total Value

$999,998.00

Shares Owned

4,673,891

Trade Date

Thursday, December 18, 2025

66 days ago

SEC Filing Date

Monday, December 22, 2025

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Kyverna Therapeutics, Inc.

Company Overview

No company information available
View news mentioning KYTX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/2445974

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime